Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes

Progress in Retinal and Eye Research

Volumn 24, Issue 3, 2005, Pages 355-377

  Cunha Vaz, José ^a   Bernardes, Rui ^b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALLOXAN; ENDOTHELIN; ENDOTHELIN CONVERTING ENZYME; FLUORESCEIN; HEMOGLOBIN A1C; INSULIN; NEURONAL NITRIC OXIDE SYNTHASE; STREPTOZOCIN;

ALLOXAN DIABETES MELLITUS; BLOOD RETINA BARRIER; CAPILLARY FLOW; CLINICAL FEATURE; COMPUTER PROGRAM; DIABETIC RETINOPATHY; DISEASE CONTROL; DISEASE DURATION; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FLUOROMETRY; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLIA CELL; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MICROANEURYSM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETINA; RETINA AMACRINE CELL; RETINA CAPILLARY; RETINA HEMORRHAGE; RETINA MACULA LUTEA; REVIEW; SCANNING LASER OPHTHALMOSCOPY; STREPTOZOCIN DIABETES; VASCULAR DISEASE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 13744249120     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2004.07.004     Document Type: Review

References (107)

1. L.P. Aiello, T.W. Gardner, G.L. King, G. Blankenship, J.D. Cavallerano, F.L. Ferris III, and R. Kein Diabetic retinopathy Diabetes Care 21 1998 143 156
2. A. Ang, L. Tong, and S.A. Vernon Improvement of reproducibility of macular volume measurements using the Heidelberg retinal tomograph Br. J. Ophthalmol. 84 2000 1194 1197
3. Antonetti, D.A., Barber, A.J., Khin, S., Lieth, E., Tarbell, J.M., Gardner, T.W., Penn State Retina Research Group, 1998. Vascular permeability in experimental diabetes is associated with reduced endothelial occluding content. Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Diabetes 47, 1953-1959.
4. N. Ashton Studies of retinal capillaries in relation to diabetic and others retinopathies Br. J. Ophthalmol. 47 1963 521 538
5. N. Ashton The blood-retinal barrier and vasoglial relationships in retinal disease Trans. Ophthalmol. Soc. UK 85 1965 199 230
6. N. Ashton Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973 Br. J. Ophthalmol. 58 1974 344 347
7. R. Bernardes, C. Lobo, and J.G. Cunha-Vaz Multimodal macula mapping a new approach to study diseases of the macula Surv. Ophthalmol. 47 2002 580 589
8. D. Boeri, M. Maiello, and M. Lorenzi Increased prevalence of microthromboses in retinal capillaries of diabetic individuals Diabetes 50 2001 1432 1439
9. M. Brownlee Glycation and diabetic complications (Lilly lecture 1993) Diabetes 43 1994 836 841
10. S.E. Bursell, A.C. Clermont, B.T. Kinsley, D.C. Simonson, L.M. Aiello, and H.A. Wolpert Retinal blood flow changes in patients with insulin-dependent Diabetes mellitus and no diabetic retinopathy - a video fluorescein angiography study Invest. Ophthalmol. 37 1996 886 897
11. F. Cambien, O. Poirier, L. Lecerf, A. Evans, J.-P. Cambou, D. Arveiler, G. Luc, J.-M. Bard, L. Bara, S. Ricard, L. Tiret, P. Amouyel, F. Alhenc-Gelas, and F. Soubrier Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction Nature 359 1992 641 644
12. A. Carmo, P. Ramos, A. Reis, R. Proença, and J.G. Cunha-Vaz Breakdown of the inner and outer blood-retinal barriers in streptozotocin- induced diabetes Exp. Eye. Res. 67 1998 569 575
13. A.C. Clermont, L.P. Aiello, F. Mori, L.M. Aiello, and S.E. Bursell Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy Am. J. Ophthalmol. 124 1997 433 436
14. D.G. Cogan, and T. Kwabara Capillary shunts in the pathogenesis of diabetic retinopathy Diabetes 12 1963 293 300
15. J.G. Cunha-Vaz Pathophysiology of diabetic retinopathy Br. J. Ophthalmol. 62 1978 351 355
16. J.G. Cunha-Vaz Perspectives in the treatment of diabetic retinopathy Diabetes/Metabolism Rev. 8 1992 105 116
17. J.G. Cunha-Vaz Blood-retinal barrier in diabetes P. van Bijsterveld Diabetic Retinopathy 2000 Taylor & Francis, A Martin Dunitz London 155 168
18. J.G. Cunha-Vaz Diabetic Retinopathy. Surrogate Outcomes for drug development for diabetic retinopathy Ophthalmologica 214 2000 377 380
19. J.G. Cunha-Vaz, and A. Travassos Breakdown of the blood-retinal barriers and cystoid macular edema Surv. Ophthalmol. 28 1984 485 492
20. J.G. Cunha-Vaz, J.R. Faria de Abreu, A.J. Campos, and G.M. Figo Early breakdown of the blood-retinal barrier in diabetes Br. J. Ophthalmol. 59 1975 649 656
21. J.G. Cunha-Vaz, J.R. Fonseca, and J.F. Faria de Abreu Vitreous fluorophotometry and retinal blood flow studies in proliferative retinopathy Albrecht Graefe's Arch. Klin. Exp. Ophthalmol. 207 1978 71 76
22. J.G. Cunha-Vaz, J.R. Gray, R.C. Zeimer, M.C. Mota, B.M. Ishimoto, and E. Leite Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry Diabetes 34 1985 53 59
23. J.G. Cunha-Vaz, C.C. Mota, E.C. Leite, J.R. Abreu, and M.A. Ruas Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy Arch. Ophthalmol. 103 1985 1307 1311
24. J.G. Cunha-Vaz, C.C. Mota, E.C. Leite, J.R. Abreu, and M.A. Ruas Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy Diabetes 35 1986 574 578
25. J.G. Cunha-Vaz, C. Lobo, J.P. Castro Sousa, B. Oliveiros, E. Leite, and J.R. Faria de Abreu Progression of retinopathy and alteration of the blood-retinal barrier in patients with type 2 diabetes a seven-year prospective follow-up study Graefe's Arch.Clin. Exp. Ophthalmol. 236 1998 264 268
26. M.H.M. Cuypers, J.S. Kasanardjo, and B.C.P. Polak Retinal blood flow changes in diabetic retinopathy measured with the Heidelberg scanning laser Doppler flowmeter Graefes Clin. Arch. Exp. Ophthalmol. 238 2000 935 941
27. S. Darius, G. Wolf, P.L. Huang, and M.C. Fishman Localization of NADPH-diaphorase/nitric oxide synthase in the rat retina an electron microscopic study Brain Res. 690 1995 231 235
28. D. Deng, T. Evans, K. Mukherjee, D. Downey, and S. Chakrabarti Diabetes-induced vascular dysfunction in the retina role of endothelins Diabetologia 42 1999 1228 1234
29. Diabetes Control and Complications Trials Group, 2002. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287, 2563-2569.
30. Diabetic Retinopathy Study Research Group Photocoagulation treatment of proliferative diabetic retinopathy Clinical application of Diabetic Retinopathy Study (DRS) findings Diabetic Retinopathy Study (DRS) Report Number 5. Dev. Ophthalmol. 2 1981 248 261
31. Early Treatment Diabetic Retinopathy Study Research Group, 1991. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report Number 12. Ophthalmology 98, 823-833.
32. R.L. Engerman Animal models of diabetic retinopathy Trans. Am. Acad. Otolaryngol. 81 1976 710 715
33. C. Engler, B. Krogsaa, and H. Lund-Andersen Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics Graefe's Arch. Clin. Exp. Ophthalmol. 229 1991 442 446
34. F. Ferris, and M. Davis Treating 20/20 eyes with diabetic macula edema Arch. Ophthalmol. 117 1990 675 676
35. D.S. Fong, and F. Ferris Practical management of diabetic retinopathy Focal Points 21 3 2003 1 17
36. P. Fritsche, R. VanderHeijde, M.S.A. Suttorp-schulten, and B.C. Pollack Retinal thickness analysis (RTA). An objective method to assess and quantify the retinal thickness in healthy controls and diabetics without diabetic retinopathy Retina 22 2002 768 771
37. Gardner, T.W., Aiello, L.P., 2000. Pathogenesis of diabetic retinopathy. In: Flynn Jr., H.W., Smiddy, W.E. (Eds.), Diabetes and Ocular Disease:Past, Present, and Future Therapies, AAO Monograph No. 14. The Foundation of the American Academy of Ophthalmology, San Francisco, pp. 1-17.
38. A. Garner Pathogenesis of diabetic retinopathy Semin. Ophthalmol. 2 1987 4 11
39. G. Ghirlanda, M.A.S. Di Leo, S. Caputo, S. Cercone, and A.V. Greco From functional to microvascular abnormalities in early diabetic retinopathy Diabetes Metab. Rev. 13 1997 15 35
40. Goldberg, M. F., Fine, S.L., (Eds.), 1969. Symposium on treatment of Diabetic Retinopathy. Washington, DC, US Department of Health, Education and Welfare.
41. W.F. Graier, T.C. Wascher, L. Lockner, H. Toplak, G.J. Krejs, and W.R. Kukovetz Exposure to elevated d-glucose concentrations modulates vascular endothelial cell vasodilatory responses Diabetes 42 1993 1497 1505
42. J.D. Grange Retinopathie Diabétique. Rapport à la Société Française d'Ophthalmologie 1995 Masson Paris
43. D.A. Greene, S.A. Lattimer, and A.A.F. Sima Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications N. Engl. J. Med. 316 1987 599 606
44. T. Hasegawa, J.R. Ravens, J.F. Toole, and W. Salem Precapillary arteriovenous anastomoses "thoroughfare channels" in the brain Arch. Neurol. 16 1967 217 224
45. M.R. Hee, C.A. Puliafito, C. Wong, J.S. Duker, E. Reichel, B. Rutledge, J.S. Schun, E.A. Swanson, and J.G. Fujimoto Quantitative assessment of macular edema with optical coherence tomography Arch. Ophthalmol. 113 8 1995 1019 1029
46. M.R. Hee, C.A. Puliafito, J.C. Duker, E. Reichel, J.G. Coker, J.R. Wilkins, J.S. Schuman, E.A. Swanson, and J.G. Fujimoto Topography of diabetic macular edema with optical coherence tomography Ophthalmology 105 1998 360 370
47. T. Hellstedt, and I. Immonen Disappearance and formation rates of microaneurysms in early diabetic retinopathy Br. J. Ophthalmol. 80 1996 135 139
48. H. Holländer, F. Makarov, Z. Dreher, D. van Driel, T. Chan Ling, and J. Stone Structure of the macroglia of the retina sharing and division of labour between astrocytes and Müeller cells J. Comput. Neurol. 313 1991 587 603
49. H.L. Hudson, M.H. Stickand, S. Futers, and P.J. Grant Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy Diabetes 50 2001 105:1511
50. S.E. Humphries, P.H. Talmud, and H. Montgomery Gene-environment interaction lipoprotein lipase and smoking and risk of CAD and the ACE and exercise-induced left ventricular hypertrophy as examples S. Malcom J. Gooship Genotype to Phenotype 2001 Bios Scientific Oxford 55 72
51. H. Ishii, M.R. Jirousek, D. Koya, C. Takagi, P. Xia, A. Clermont, S.E. Bursell, T.S. Kern, L.M. Ballas, W.F. Heath, L.E. Stramm, E.P. Feener, and G.L. King Amelioration of vascular dysfunctions in diabetic rats by an oral PKC ß inhibitor Science 272 1996 728 731
52. L. Kageman, A. Harris, H.S. Chung, V.P. Costa, and H. Gargozi Basics and limitations of color Doppler imaging L.E. Pillmat A. Harris D.R. Anderson E.L. Greve Current Concepts on Ocular Blood Flow in Glaucoma 1999 Kugler The Hague 103 110
53. Keavney, B., McKenzie, C., Parish, S., Palmer, A., Clark, S., Youngman, L., Delépine, M., Latharop, M., Peto, R., Collins, R., International Studies of Infarct Survial (ISIS) Collaborators, 2000. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 355, 434-442.
54. H. Keen, and C. Chlouverakis Metabolic factors in diabetic retinopathy C.N. Graymore Biochemistry of the Retina 1965 Academic Press New York 123
55. R. Klein, B.E.K. Klein, S.E. Moss, and K.J. Cruikschanks The Wisconsin epidemiologic study of diabetic retinopathy. XV the long-term incidence of macular edema Ophthalmology 102 1995 7 16
56. R. Klein, S.M. Meuer, S.E. Moss, and B.E.K. Klein Retinal microaneurysms counts and 10-year progression of diabetic retinopathy Arch. Ophthalmol. 113 1995 1386 1391
57. J.A. Klystra, J.C. Brown, G.J. Jaffe, T.A. Cox, R. Gallemore, C.M. Greven, J.G. Hall, and D.E. Eifrig The importance of fluorescein angiography in planning laser treatment of diabetic macular edema Ophthalmology 106 1999 2068 2073
58. Kohner, E.M., 1977. The problem of retinal blood flow in diabetes. In: Selected Topics in Diabetes, Proceedings of Int. Meeting Carlo Erba, S.p.A., Milan, Italy, pp. 15-24.
59. E.M. Kohner, and C.T. Dollery The rate formation and disappearance of microaneurysms in diabetic retinopathy Eur. J. Clin. Invest. 1 1970 167 171
60. E.M. Kohner, A.M. Hamilton, S.J. Saunders, B.A. Sutcliffe, and C.J. Bulpitt The retinal blood flow in diabetes Diabetologica 27 1975 48 52
61. Kohner, E.M., Sleightholm, M., The KROC collaborative study group., 1986. Does microaneurysm count reflect severity of early diabetic retinopathy? Ophthalmology 93, 586-589.
62. R.D.G. Leslie, and D.A. Pyke Diabetic retinopathy in identical twins Diabetes 31 1982 19 21
63. Lieth, E., Barber, A.J., Xu, B., Dice, C., Ratz, M.J., Tanase, D., Strother J.M., Penn State Retina Research Group, 1998. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 47, 815-820.
64. C.L. Lobo, R.C. Bernardes, F.J. Santos, and J.G. Cunha-Vaz Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous Arch. Ophthalmol. 117 1999 631 637
65. C.L. Lobo, R.C. Bernardes, and J.G. Cunha-Vaz Alterations of the blood-retinal barriers and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes Arch. Ophthalmol. 118 2000 1664 1669
66. C.L. Lobo, R.C. Bernardes, J.P. Figueira, J.R. Faria de Abreu, and J.G. Cunha-Vaz Three-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy Arch. Ophthalmol. 122 2004 211 217
67. M. Lorenzi, and C. Gerhardinger Early cellular and molecular changes induced by diabetes in the retina Diabetologia 44 2001 791 804
68. J. Ludovico, R. Bernardes, I. Pires, J. Figueira, C. Lobo, and J. Cunha-Vaz Alterations of retinal capillary blood flow in preclinical retinopathy in subjects with type 2 diabetes Graefe's Arch. Clin. Exp. Ophthalmol. 241 2003 181 186
69. T. Malmfors The adrenergic innervation of the eye as demonstrated by fluorescence microscopy Acta. Physiol. Scand. 65 1965 259 266
70. A. Matsumoto, Y. Iwashima, A. Abiko, A. Morikawa, M. Sekiguchi, M. Eto, and I. Makino Detection of the association between a deletion polymorphism in the gene encoding angiotensin I-converting enzyme and advanced diabetic retinopathy Diabetes Res. Clin. Pract. 50 2000 195 202
71. G. Michelson, J. Welzenbach, I. Pal, and J. Harazny Automatic full fields analysis of perfusion images gained by scanning laser Doppler flowmetry Br. J. Ophthalmol. 82 1998 1294 1300
72. G. Michelson, J. Welzenbach, I. Pal, and J. Harazny Functional imaging of the retinal microvasculature by scanning laser Doppler flowmetry Int. Ophthalmol. 23 2001 327 333
73. T. Murata, T. Ishibashi, and H. Inomata Immunohistochemical detection of blood-retinal barrier breakdown in streptozotocin-diabetic rats Graefe's Arch. Clin. Exp. Ophthalmol. 231 1993 175 177
74. A. Patel, M.L. Hibberd, B.A. Millward, and A.G. Demaine Chromosome 7q35 and susceptibility to diabetic micro-vascular complications J. Diabetes Complications 10 1996 62 67
75. I. Pires, R.C. Bernardes, C.L. Lobo, M.A. Soares, and J.G. Cunha-Vaz Retinal thickness in eyes with mild nonproliferative retinopathy in patients with type 2 diabetes mellitus Comparison of measurements obtained by retinal thickness analysis and optical coherence tomography Arch. Ophthalmol. 120 2002 1301 1306
76. C.L. Poitry-Yamate, S. Poitry, and M. Tsacopoulos Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina J. Neurosci. 15 1965 5179 5191
77. M. Rema, G. Saravan, R. Deepa, and V. Mohan Familial clustering of diabetic in South Indian Type diabetic patients Diabet. Med. 19 11 2002 910 916
78. B. Rigat, C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J. Clin. Invest. 86 1990 1343 1346
79. E. Rungger-Brändle, A.A. Dosso, and P.M. Leuenberger Glial reactivity, an early feature of diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 41 2000 1971 1980
80. M. Serrano-Rios, J.R. Regueiro, R. Serverino, C. Lopez-Larrea, and A. Arnaiz-Villena HLA antigens in insulin dependent and non-insulin dependent Spanish diabetic patients Diabetes Metab. 9 1983 116 120
81. M. Shahidi, R. Zeimer, and M. Mori Topography of retinal thickness in normals Ophthalmology 97 1990 1120 1197
82. M. Shahidi, Y. Ogura, N.P. Blair, M.M. Rusin, and R. Zeimer Retinal thickness analysis for quantitative assessment of diabetic macular edema Arch. Ophthalmol. 109 1991 1115 1119
83. M. Shahidi, Y. Ogura, N.P. Blair, and R. Zeimer Retinal thickness change after focal laser treatment of diabetic macular oedema Br. J. Ophthalmol. 78 11 1994 827 830
84. M. Shakib, and J.G. Cunha-Vaz Studies on the permeability of the blood-retinal barrier. IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier Exp. Eye Res. 5 1966 229 234
85. 1C levels are genetically determined even in type 1 diabetes. Evidence from healthy and diabetic twins Diabetes 50 2001 2858 2863
86. L.L. Stewart, L.L. Field, S. Ross, and R.G. McArthur Genetic risk factors in diabetic retinopathy Diabetologia 36 1993 1293 1298
87. C. Storm, B. Sander, N. Larsen, M. Larsen, and H. Lund-Andersen Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography Invest. Ophthalmol. Vis. Sci. 43 2002 241 245
88. Stratton, I.M., Kohner, E.M., Aldington, S.J., Turner, R.C., Holman, R.R., Manley, S.E., Matthews, D.R., for the UKPDS Group, 2001. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44, 156-163.
89. P.M. Sullivan, G.E. Davies, G. Caldwell, A.C. Morris, and E.M. Kohner Retinal blood flow during hyperglycemia a laser doppler velocimetry study Invest. Ophthalmol. Vis. Sci. 31 1990 2041 2045
90. E.E. Sutter Imaging visual function with the multifocal m-sequence techniques Vision Res. 41 2001 1241 1255
91. C. Takagi, S.E. Bursell, Y.W. Lin, H. Takagi, E. Duh, Z. Jiang, A.C. Clermont, and G.L. King Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1 Invest. Ophthalmol. Vis. Sci. 37 1996 2504 2518
92. T. Torrent-Solans, L. Duarte, R. Monteiro, E. Almeida, R. Bernardes, and J. Cunha-Vaz Red-dots counting on digitalized fundus images of mild nonproliferative retinopathy in Diabetes type 2 Invest. Ophthalmol. Vis. Sci. 2985 2004 (Abstract number 2985/B620)
93. M.O.M. Tso, J.G. Cunha-Vaz, C.Y. Shih, and C.W. Jones Clinicopathologic study of blood-retinal barrier in experimental diabetes mellitus Arch. Ophthalmol. 98 1980 2032 2040
94. United Kingdom Prospective Diabetes Study Diabetic retinopathy at diagnosis of type 2 diabetes and associated risk factors Arch. Ophthalmol. 116 1998 297 303
95. H.J. Van Schaik, B. Heintz, M. Larsen, E. Leite, V. Rosas, R. Schalnus, and J.A. Van Best Permeability of the blood-retinal barrier in healthy humans. European concerted action on ocular fluorometry Graefe's Arch. Clin. Exp. Ophthalmol. 235 1997 639 646
96. S.A. Viñores, R. McGehee, A. Lee, C. Gadegbeku, and P.A. Campochiaro Ultrastructural localization of blood retinal-barrier breakdown in diabetic and galactosemic rats J. Histochem. Cytochem. 38 1990 1341 1352
97. S.A. Viñores, E. Van Niel, J.L. Swerdloff, and P.A. Campochiaro Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium Histochem. J. 25 1993 648 663
98. S.R. Waltman Sequential vitreous fluorophotometry in diabtes mellitus a five year prospective study Trans. Am. Ophthalmol. Soc. 82 1989 827 940
99. S.R. Waltman, T. Krupin, S. Hanish, C. Oestrich, and B. Becker Alteration of the blood-retinal barrier in experimental diabetes mellitus Arch. Ophthalmol. 96 1978 878 879
100. S.R. Waltman, C. Oestrich, T. Krupin, S. Hanish, S. Ratzan, J. Santiago, and C. Kilo Quantitative vitreous fluorophotometry a sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients Diabetes 27 1978 85 87
101. K.M. Warpeha, and U. Chakravarthy Molecular genetics of microvascular disease in diabetic retinopathy Eye 17 2003 305 311
102. K.M. Warpeha, F. Ah-Fat, S. Harding, C.C. Patterson, W. Xu, P.M. Hart, U. Chakravarthy, and A.E. Hughes Dinucleotide repeat polymorphisms in EDN1 and NOS3 are not associated with severe diabetic retinopathy in type 1 or type 2 diabetes Eye 13 1999 174 178
103. L.E. Wasgenknecht, D.W. Bowden, J.J. Carr, C.D. Langefeld, B.I. Freedman, and S.S. Rich Familial aggregation of coronary artery calcium in families with type 2 diabetes Diabetes 50 2001 861 866
104. Wilkinson, C.P., Ferris III, F.L., Klein, R.E., Lee, P.P., Agardh, C.D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., Verdaguer, J.T., representing the Global Diabetic Retinopathy Project Group, 2003. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 101, 1677-1682.
105. Wise, G.N., Dollery, C.T., Henkid, P., 1971. The Retinal Circulation. Harper & Row, New York, pp. 421-454.
106. R. Zeimer Application of retinal thickness analyzer to the diagnosis and management of ocular diseases Ophthalmol. Clin. North America 11 1998 359 379
107. R.C. Zeimer, N.P. Blair, and J.G. Cunha-Vaz Vitreous fluorophotometry for clinical research. I. Description and evaluation of a new fluorophotometer Arch. Ophthalmol. 101 1983 1753 1756